OPGEN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5149 USD | -3.21% |
|
-18.27% | +22.60% |
| 04-24 | OpGen Gets Notice of Noncompliance From Nasdaq | MT |
| 03-26 | Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading | MT |
Chart calendar OpGen, Inc.
21263af95acebf7fc7a5255a8be0967b.n2_MgujDKDFmOod68Uvtbh31BIx1Erit0Sn1uYagEFU.xQ767tDyWgUqCLA4hh66Q3yiVM4jXdX74kTF0-v_VgbXHrjU2I5BVSBVyg~e0bd109856f65dae4a48a39a0de9361f
Upcoming events on OpGen, Inc.
Past events on OpGen, Inc.
| 14/11/2023 21:30 | Q3 2023 Earnings Release |
| 08/09/2023 15:00 | Extraordinary Shareholders Meeting |
| 10/08/2023 21:30 | Q2 2023 Earnings Call |
| 10/08/2023 21:15 | Q2 2023 Earnings Release |
| 30/06/2023 15:00 | Extraordinary Shareholders Meeting |
| 16/06/2023 | ASM Microbe Conference |
| 07/06/2023 15:00 | Annual General Meeting |
| 15/05/2023 21:30 | Q1 2023 Earnings Call |
| 15/05/2023 21:15 | Q1 2023 Earnings Release |
| 29/03/2023 21:30 | Q4 2022 Earnings Call |
| 29/03/2023 21:15 | Q4 2022 Earnings Release |
| 01/02/2023 05:00 | Channelchek Takeaway Series - The J.P.Morgan Healthcare Conference |
| 10/11/2022 21:30 | Q3 2022 Earnings Call |
| 10/11/2022 21:10 | Q3 2022 Earnings Release |
| 12/09/2022 21:00 | H.C. Wainwright Global Investment Conference |
| 11/08/2022 21:30 | Interim 2022 Earnings Call |
| 11/08/2022 21:15 | Interim 2022 Earnings Release |
| 09/06/2022 15:00 | Annual General Meeting |
| 12/05/2022 21:30 | Q1 2022 Earnings Call |
| 12/05/2022 21:15 | Q1 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,95 2,89 1.83% | 3,50 3,49 0.36% | 4,21 4,08 3.4% | 4,31 4,13 4.29% | 2,61 3,17 -17.8% |
|
EBITDA Million USD | Released Forecast Spread | -12,4 0,00 - | -10,8 -12,3 12.22% | -19,6 -22,3 12.06% | -20,4 -26,2 22.09% | -20,6 -19,9 -3.4% |
|
EBIT Million USD | Released Forecast Spread | -13,2 -12,5 -5.56% | -11,8 -12,6 6.95% | -22,7 -22,0 -3.09% | -23,3 -24,0 2.96% | -34,6 -22,2 -55.71% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,4 -12,7 -5.65% | -12,4 -12,8 3.06% | -26,1 -25,8 -1.25% | -34,8 -33,1 -4.99% | -37,3 -24,9 -49.73% |
|
Net income Million USD | Released Forecast Spread | -13,4 -12,7 -5.65% | -12,4 -13,1 5.28% | -26,2 -26,2 -0.2% | -42,0 -35,6 -17.75% | -37,3 -24,9 -49.73% |
|
EPS USD | Released Forecast Spread | -888 -814 -9.09% | -154 -152 -1.38% | -33,2 -33,1 -0.4% | -22,8 -19,5 -17.12% | -15,3 -12,9 -18.37% |
| Announcement Date | 26/02/19 | 24/03/20 | 25/03/21 | 29/03/22 | 29/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,24 1,20 3.26% | 1,43 1,40 1.83% | 0,47 1,05 -55.26% | 0,97 1,00 -3.28% | 0,45 0,40 12.18% | 0,72 | 0,91 | 0,74 0,90 -18.21% | 0,70 0,85 -17.76% |
|
EBIT Million USD | Released Forecast Spread | -5,09 -6,16 17.46% | -5,92 -5,41 -9.36% | -5,85 -6,03 3.06% | -5,27 -5,93 11.12% | -13,5 -5,50 -145.7% | -9,94 -5,60 -77.42% | -5,07 | -5,16 -4,90 -5.17% | -3,57 -4,53 21.29% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,06 -7,31 17.17% | -6,86 -6,46 -6.18% | -6,80 -7,23 5.9% | -5,84 -7,03 16.94% | -14,1 -6,10 -131.21% | -10,5 -6,10 -72.7% | -5,83 -5,52 -5.51% | -4,06 -5,15 21.11% | |
|
Net income Million USD | Released Forecast Spread | -6,06 -7,31 17.17% | -14,1 -6,46 -117.76% | -6,80 -7,23 5.9% | -5,84 -7,03 16.94% | -14,1 -6,10 -131.21% | -10,5 -6,10 -72.7% | -5,83 -5,52 -5.51% | -4,06 -5,15 21.11% | |
|
EPS USD | Released Forecast Spread | -3,20 -3,80 15.79% | -7,00 -3,10 -125.81% | -3,00 -3,20 6.25% | -2,60 -3,00 13.33% | -6,00 -2,40 -150% | -3,87 -2,00 -93.5% | -0,93 -0,71 -30.99% | -0,46 -0,43 -6.98% | |
| Announcement Date | 11/11/21 | 29/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 29/03/23 | 15/05/23 | 10/08/23 | 14/11/23 |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for OpGen, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OPGN Stock
- Calendar OpGen, Inc.
